Friday, February 18, 2022 2:31:48 PM
Big Pharma Success, Government Failure The U.S. ordered too few courses of the new and promising Covid pills.
wsj.com
WSJ Opinion: Omicron, Booster Shots and Learning to Live With Covid-19
https://www.wsj.com/articles/big-pharma-success-government-failure-covid-pills-merck-molnupiravir-pfizer-paxlovid-ridgeback-11640295905
Covid-19 is an ever-mutating virus, so rather than panic and reimpose pandemic restrictions when new strains like Delta and Omicron are discovered, the world should learn to live with them. Image: Christopher Furlong/Getty Images Composite: Mark Kelly
wsj.com
WSJ Opinion: Omicron, Booster Shots and Learning to Live With Covid-19
https://www.wsj.com/articles/big-pharma-success-government-failure-covid-pills-merck-molnupiravir-pfizer-paxlovid-ridgeback-11640295905
Covid-19 is an ever-mutating virus, so rather than panic and reimpose pandemic restrictions when new strains like Delta and Omicron are discovered, the world should learn to live with them. Image: Christopher Furlong/Getty Images Composite: Mark Kelly
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
